SciSparc Secures Strategic Advantage with Grant of European

TEL AVIV, Israel, May 31, 2024 -- SciSparc Ltd. , a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders and rare diseases of the central...

Related Keywords

United States , Australia , Canada , Japan , Israel , , Trademark Office , Scisparc Ltd , European Patent Office , Company Or Scisparc , Exchange Commission , World Health Organization , Nasdaq , United States Patent , Tourette Syndrome , Looking Statements , Private Securities Litigation Reform Act , Annual Report ,